Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.34 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.34 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.34 |
| ▸ | PYGB | P11216 | 2/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | AMY2A | P04746 | 2/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19966790 | 1.00 | L3MBTL1 (0.42) | L3MBTL1MAPTAMY1AKDM4EALDH1A1 | |
| SCHEMBL24778537 | 0.86 | L3MBTL1 (0.40) | L3MBTL1MAPTAMY1ALGALS3LGALS1 | |
| SCHEMBL23639953 | 0.83 | L3MBTL1 (0.40) | L3MBTL1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL17811737 | 0.81 | AMY1A (0.41) | L3MBTL1MAPTAMY1AALDH1A1AMY2A | |
| SCHEMBL19261577 | 0.79 | L3MBTL1 (0.44) | L3MBTL1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL19261576 | 0.79 | L3MBTL1 (0.44) | L3MBTL1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL24518019 | 0.77 | LGALS1 (0.52) | L3MBTL1MAPTLGALS3LGALS1LGALS8 | |
| SCHEMBL17035736 | 0.77 | LGALS1 (0.52) | L3MBTL1MAPTLGALS3LGALS1LGALS8 | |
| SCHEMBL21610360 | 0.77 | LGALS1 (0.52) | L3MBTL1MAPTLGALS3LGALS1LGALS8 | |
| SCHEMBL9915196 | 0.77 | LGALS1 (0.52) | L3MBTL1MAPTLGALS3LGALS1LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | NEMIS TECHNOLOGIES AG (CH) | 2021-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214607-A1 | LONG WAVELENGTH EMITTING CHEMILUMINESCENT PROBES | VEGFA, GUSB, NR2E3 | L3MBTL1 562/4885MAPT 3254/4885AMY1A 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.